26 results on '"Bhella, Sita"'
Search Results
2. Very late relapse in Hodgkin lymphoma: Characterizing an understudied population
3. Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
4. Review of CAR T-Cell Therapy in Multiple Myeloma: A Canadian Perspective.
5. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation
6. A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score
7. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation
8. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation
9. Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.
10. An Online Educational Module to Improve General Internal Medicine Trainees' Knowledge and Comfort in Managing Acute Complications of Sickle Cell Disease.
11. Genetics of Pigmentation in Porcellio scaber Latreille, 1804 (Isopoda, Oniscidea)
12. Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma.
13. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
14. Long-term follow up of relapsed/refractory non-Hodgkin lymphoma patients treated with single-agent selinexor – a retrospective, single center study.
15. Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF+/−plerixafor.
16. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.
17. Obstetric and trauma database review at a single institution finds the optimal maternal age restriction for the transfusion of O– blood to women involved in trauma to be 45 years
18. Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains.
19. Predictors of response to intra-articular steroid injection in psoriatic arthritis
20. Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis
21. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
22. Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
23. 265 - Outcomes of Secondary Acute Lymphoblastic Leukemia: Case Report and Literature Review of 198 Cases.
24. Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
25. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
26. Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.